Toosendanin/OVA

• Background:

  1. Toosendanin (TSN) was used as a digestive tract-parasiticide and agricultural insecticide in ancient China; TSN is a selective presynaptic blocker and an effective antibotulismic agent, by interfering with neurotransmitter release through an initial facilitation followed by a subsequent depression. 2. Toosendanin has antifeedant and growth inhibitory effects, it can significantly deter feeding of 2nd- and 4th-instar larvae in diet choice and leaf disc choice bioassays, resp. 3. Toosendanin can induces outgrowth of neuronal processes and apoptosis in PC12 cells. 4. Toosendanin to be a novel L-type Ca 2+ channel agonist, which possesses a distinct binding site from BayK8644. 5. Toosendanin has effects on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-60 cells.

• Expression System:

  Native protein

• Conjugation:

  Unconjugated

• Tag:

  No tag

• Source:

  Small molecule-conjugated carrier protein

• Applications:

  Others

• Endotoxin:

  Not Tested

• Purity:

  >95% by SDS-PAGE

• Buffer:

  0.01M PBS (pH7.4)

• Storage Conditions:

  Store at -70°C or -20°C. Avoid repeated freeze/thaw cycles.